Lördag 25 Oktober | 22:14:04 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-03-05 08:00 Kvartalsrapport 2026-Q2
2025-11-07 N/A X-dag ordinarie utdelning HEALTH 0.00 EUR
2025-11-06 N/A Årsstämma
2025-09-18 - Bokslutskommuniké 2025
2025-03-06 - Kvartalsrapport 2025-Q2
2024-11-11 - X-dag ordinarie utdelning HEALTH 0.00 EUR
2024-11-08 - Årsstämma
2024-09-20 - Bokslutskommuniké 2024
2024-03-07 - Kvartalsrapport 2024-Q2
2023-11-17 - X-dag ordinarie utdelning HEALTH 0.00 EUR
2023-11-16 - Årsstämma
2023-09-28 - Bokslutskommuniké 2023
2023-04-24 - Extra Bolagsstämma 2023
2023-03-23 - Kvartalsrapport 2023-Q2
2022-11-17 - Årsstämma
2022-10-25 - X-dag ordinarie utdelning HEALTH 0.00 EUR
2022-09-29 - Bokslutskommuniké 2022
2022-06-29 - Extra Bolagsstämma 2022
2022-02-24 - Kvartalsrapport 2022-Q2
2021-10-29 - X-dag ordinarie utdelning HEALTH 0.00 EUR
2021-10-28 - Årsstämma
2021-09-15 - Bokslutskommuniké 2021

Beskrivning

LandFinland
ListaSmall Cap Helsinki
SektorHälsovård
IndustriMedicinteknik
Nightingale Health är verksamt inom medicinteknik. Bolaget är specialiserat inom utveckling av medicintekniska produkter. Produktportföljen är bred och inkluderar plattformar och tjänster inom blodanalyser som används i sjukdomsförebyggande syfte. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs globalt med störst närvaro inom Europa.
2025-10-02 08:00:00

Nightingale Health Plc | Stock Exchange Release | October 02, 2025 at 09:00:00 EEST

Nightingale Health Plc’s Annual Report for financial year 1 July 2024–30 June 2025 has been published. The publication includes the Board of Directors' Report, the Consolidated and Parent Company Financial Statements, the Corporate Governance Statement, and the Remuneration Report.

The Annual Report is attached to this release, and is also available on Nightingale Health’s website https://ir.nightingalehealth.com/financial-reports. The Corporate Governance Statement will be available also at https://ir.nightingalehealth.com/corporate-governance-statements, and the Remuneration Report at https://ir.nightingalehealth.com/remuneration-reports.

Nightingale Health Plc publishes the financial statements also in XHTML format in accordance with the European Single Electronic Format (ESEF) reporting requirements. In line with the ESEF requirements, the primary statements in the consolidated financial statements have been labelled with XBRL tags. Notes to financial statements have been labelled with XBRL block tags. The audit firm PricewaterhouseCoopers Oy has provided an independent auditor’s reasonable assurance report on Nightingale Health’s ESEF Financial Statements in accordance with ISAE 3000 (Revised). The ESEF financial statements in Finnish are available in the zip file attached to this release and at https://ir.nightingalehealth.com/financial-reports.